969 related articles for article (PubMed ID: 25683490)
41. Silibinin inhibits myofibroblast transdifferentiation in human tenon fibroblasts and reduces fibrosis in a rabbit trabeculectomy model.
Chen YH; Liang CM; Chen CL; Chen JT; Chang YH; Lu DW; Chien KH; Tai MC
Acta Ophthalmol; 2013 Nov; 91(7):e506-15. PubMed ID: 23764119
[TBL] [Abstract][Full Text] [Related]
42. Thrombospondin-4 critically controls transforming growth factor β1 induced hypertrophic scar formation.
Qian W; Li N; Cao Q; Fan J
J Cell Physiol; 2018 Jan; 234(1):731-739. PubMed ID: 30132849
[TBL] [Abstract][Full Text] [Related]
43. Curcumin alleviates hypertrophic scarring by inhibiting fibroblast activation and regulating tissue inflammation.
Fei H; Qian Y; Pan T; Wei Y; Hu Y
J Cosmet Dermatol; 2024 Jan; 23(1):227-235. PubMed ID: 37400988
[TBL] [Abstract][Full Text] [Related]
44. [Signal roles of protein tyrosine kinase in transforming growth factor-beta1, or interferon-gamma regulated proliferation and collagen synthesis by fibroblasts from hypertrophic scar and normal dermis].
Zhang XF; Li HY; Lu KH; Guo SZ; Zhang LX
Zhonghua Zheng Xing Wai Ke Za Zhi; 2005 Jan; 21(1):36-9. PubMed ID: 15844596
[TBL] [Abstract][Full Text] [Related]
45. Sequential analysis of myofibroblast differentiation and transforming growth factor-β1/Smad pathway activation in murine pulmonary fibrosis.
Usuki J; Matsuda K; Azuma A; Kudoh S; Gemma A
J Nippon Med Sch; 2012; 79(1):46-59. PubMed ID: 22398790
[TBL] [Abstract][Full Text] [Related]
46. Pirfenidone attenuates the profibrotic contractile phenotype of differentiated human dermal myofibroblasts.
Wells AR; Leung KP
Biochem Biophys Res Commun; 2020 Jan; 521(3):646-651. PubMed ID: 31679692
[TBL] [Abstract][Full Text] [Related]
47. Resveratrol Inhibits Proliferation and Induces Apoptosis of Pathological Scar Fibroblasts Through the Mechanism Involving TGF-β1/Smads Signaling Pathway.
Zhai XX; Ding JC; Tang ZM
Cell Biochem Biophys; 2015 Apr; 71(3):1267-72. PubMed ID: 25721869
[TBL] [Abstract][Full Text] [Related]
48. Ellagic acid inhibits the formation of hypertrophic scars by suppressing TGF-β/Smad signaling pathway activity.
Zhao ZJ; Wu DJ; Lv DL; Zhang BD; Chen L; Sun YQ
Chem Biol Drug Des; 2023 Oct; 102(4):773-781. PubMed ID: 37386691
[TBL] [Abstract][Full Text] [Related]
49. Effect of simvastatin on transforming growth factor beta-1-induced myofibroblast differentiation and collagen production in nasal polyp-derived fibroblasts.
Park IH; Park SJ; Cho JS; Moon YM; Moon JH; Kim TH; Lee SH; Lee HM
Am J Rhinol Allergy; 2012; 26(1):7-11. PubMed ID: 22391067
[TBL] [Abstract][Full Text] [Related]
50. Curcumin reduces cardiac fibrosis by inhibiting myofibroblast differentiation and decreasing transforming growth factor β1 and matrix metalloproteinase 9 / tissue inhibitor of metalloproteinase 1.
Ma J; Ma SY; Ding CH
Chin J Integr Med; 2017 May; 23(5):362-369. PubMed ID: 26956464
[TBL] [Abstract][Full Text] [Related]
51. Dracorhodin perchlorate induces apoptosis in primary fibroblasts from human skin hypertrophic scars via participation of caspase-3.
Zhang P; Li J; Tang X; Zhang J; Liang J; Zeng G
Eur J Pharmacol; 2014 Apr; 728():82-92. PubMed ID: 24525335
[TBL] [Abstract][Full Text] [Related]
52. Adipose tissue-derived stem cells suppress hypertrophic scar fibrosis via the p38/MAPK signaling pathway.
Li Y; Zhang W; Gao J; Liu J; Wang H; Li J; Yang X; He T; Guan H; Zheng Z; Han S; Dong M; Han J; Shi J; Hu D
Stem Cell Res Ther; 2016 Aug; 7(1):102. PubMed ID: 27484727
[TBL] [Abstract][Full Text] [Related]
53. Effect of heparin on production of transforming growth factor (TGF)-beta1 and TGF-beta1 mRNA expression by human normal skin and hyperplastic scar fibroblasts.
Fan SQ; Cai JL; Qin LY; Wang ZH; Liu ZZ; Sun ML
Ann Plast Surg; 2008 Mar; 60(3):299-305. PubMed ID: 18443513
[TBL] [Abstract][Full Text] [Related]
54. Interleukin-7 modulates extracellular matrix production and TGF-beta signaling in cultured human subconjunctival fibroblasts.
Yamanaka O; Saika S; Ikeda K; Miyazaki K; Ohnishi Y; Ooshima A
Curr Eye Res; 2006 Jun; 31(6):491-9. PubMed ID: 16769608
[TBL] [Abstract][Full Text] [Related]
55. Expression of Smad protein by normal skin fibroblasts and hypertrophic scar fibroblasts in response to transforming growth factor beta1.
Xie JL; Qi SH; Pan S; Xu YB; Li TZ; Liu XS; Liu P
Dermatol Surg; 2008 Sep; 34(9):1216-24; discussion 1224-5. PubMed ID: 18616749
[TBL] [Abstract][Full Text] [Related]
56. Regulatory mechanism of miR-29 over TGF-β1 and COL1 in scar cells.
Bi S; Cao C; Chai LL; Li SR; Yang DY
Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2512-2517. PubMed ID: 28617563
[TBL] [Abstract][Full Text] [Related]
57. Ski diminishes TGF-β1-induced myofibroblast phenotype via up-regulating Meox2 expression.
Chen Z; Li W; Ning Y; Liu T; Shao J; Wang Y
Exp Mol Pathol; 2014 Dec; 97(3):542-9. PubMed ID: 25445500
[TBL] [Abstract][Full Text] [Related]
58. Effect of IFN-gamma and dexamethasone on TGF-beta1-induced human fetal lung fibroblast-myofibroblast differentiation.
Gu L; Zhu YJ; Guo ZJ; Xu XX; Xu WB
Acta Pharmacol Sin; 2004 Nov; 25(11):1479-88. PubMed ID: 15525471
[TBL] [Abstract][Full Text] [Related]
59. DIM attenuates TGF-β1-induced myofibroblast differentiation in neonatal rat cardiac fibroblasts.
Li J; Zhang W; Jiao R; Yang Z; Yuan Y; Wu Q; Hu Z; Xiang S; Tang Q
Int J Clin Exp Pathol; 2015; 8(5):5121-8. PubMed ID: 26191207
[TBL] [Abstract][Full Text] [Related]
60. Protection against TGF-β1-induced fibrosis effects of IL-10 on dermal fibroblasts and its potential therapeutics for the reduction of skin scarring.
Shi JH; Guan H; Shi S; Cai WX; Bai XZ; Hu XL; Fang XB; Liu JQ; Tao K; Zhu XX; Tang CW; Hu DH
Arch Dermatol Res; 2013 May; 305(4):341-52. PubMed ID: 23321694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
